Stuart Therapeutics Announces Chief Medical and Chief Financial Officer Appointments
STUART, Fla., Feb. 1, 2024 /PRNewswire/ — Stuart Therapeutics, Inc. (“Stuart”), a clinical-stage biopharmaceutical company with candidate therapeutics in various phases of clinical development, today announced that it has…
Read more Stuart Therapeutics Announces Chief Medical and Chief Financial Officer Appointments